» Articles » PMID: 34956329

Influences Cognitive Function in Schizophrenia in Han Chinese

Overview
Journal Front Genet
Date 2021 Dec 27
PMID 34956329
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

It has been proposed that immune abnormalities may be implicated with pathophysiology of schizophrenia. The nod-like receptor pyrin domain-contraining protein 3 (NLRP3) can trigger immune-inflammatory cascade reactions. In this study, we intended to identify the role of gene encoding NLRP3 () in susceptibility to schizophrenia and its clinical features. For the mRNA expression analysis, 53 drug-naïve patients with first-episode schizophrenia and 56 healthy controls were enrolled. For the genetic study, a total of 823 schizophrenia patients and 859 controls were recruited. Among them, 239 drug-naïve patients with first-episode schizophrenia were enrolled for clinical evaluation. There is no significant difference in mRNA levels between patients with schizophrenia and healthy controls ( = 0.07). We did not observe any significant differences in allele and genotype frequencies of rs10754558 polymorphism between the schizophrenia and control groups. We noticed significant differences in the scores of RBANS attention and total scores between the patients with different genotypes of rs10754558 polymorphism ( = 0.001 and < 0.01, respectively). Further eQTL analysis presented a significant association between the rs10754558 polymorphism and in frontal cortex ( = 0.0028, = 0.028 after Bonferroni correction). Although our findings did not support confer susceptibility to schizophrenia, may be a risk factor for cognitive impairment, especially attention deficit in this disorder.

Citing Articles

In the Brain of Phosphodiesterases: Potential Therapeutic Targets for Schizophrenia.

Barbagallo F, Assenza M, Messina A Clin Psychopharmacol Neurosci. 2025; 23(1):15-31.

PMID: 39820109 PMC: 11747726. DOI: 10.9758/cpn.24.1229.


Neuroinflammatory Loop in Schizophrenia, Is There a Relationship with Symptoms or Cognition Decline?.

Carril Pardo C, Oyarce Merino K, Vera-Montecinos A Int J Mol Sci. 2025; 26(1.

PMID: 39796167 PMC: 11720417. DOI: 10.3390/ijms26010310.


The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice.

Li J, Hu T, Zhou X, Zhang T, Guo J, Wang M J Neuroinflammation. 2023; 20(1):112.

PMID: 37165444 PMC: 10173607. DOI: 10.1186/s12974-023-02791-0.

References
1.
Talukdar P, Abdul F, Maes M, Berk M, Venkatasubramanian G, Kutty B . A proof-of-concept study of maternal immune activation mediated induction of Toll-like receptor (TLR) and inflammasome pathways leading to neuroprogressive changes and schizophrenia-like behaviours in offspring. Eur Neuropsychopharmacol. 2021; 52:48-61. DOI: 10.1016/j.euroneuro.2021.06.009. View

2.
Yu L, Guo L, Fang X, Yang F, Chen Y, Wang Y . Altered brain activity in the bilateral frontal cortices and neural correlation with cognitive impairment in schizophrenia. Brain Imaging Behav. 2021; 16(1):415-423. DOI: 10.1007/s11682-021-00516-6. View

3.
Glascher J, Adolphs R, Tranel D . Model-based lesion mapping of cognitive control using the Wisconsin Card Sorting Test. Nat Commun. 2019; 10(1):20. PMC: 6318292. DOI: 10.1038/s41467-018-07912-5. View

4.
Garcia-Alvarez L, Caso J, Garcia-Portilla M, de la Fuente-Tomas L, Gonzalez-Blanco L, Saiz Martinez P . Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls. Eur Psychiatry. 2017; 47:50-59. DOI: 10.1016/j.eurpsy.2017.09.007. View

5.
Xu F, Fan W, Wang W, Tang W, Yang F, Zhang Y . Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial. Psychopharmacology (Berl). 2018; 236(4):1273-1279. DOI: 10.1007/s00213-018-5136-9. View